AZ halts COVID-19 vaccine after safety scare, as UK faces ‘second wave’It’s a bleak day in the fight against COVID-19, after the UK banned social gatherings of more than Share XAZ halts COVID-19 vaccine after safety scare, as UK faces ‘second wave’https://pharmaphorum.com/news/az-halts-covid-19-vaccine-after-safety-scare-as-uk-faces-second-wave/
Canada signs deals for J&J, Novavax COVID vaccinesThe Canadian government has reached agreements in principle with J&J and Novavax to buy their coronavirus vaccine candidates. Share XCanada signs deals for J&J, Novavax COVID vaccineshttps://pharmaphorum.com/news/canada-signs-deals-for-jj-novavax-covid-vaccines/
UK signs coronavirus vaccine deals with J&J and NovavaxThe UK is to buy millions more doses of potential coronavirus vaccines from Johnson & Johnson and Novavax, Share XUK signs coronavirus vaccine deals with J&J and Novavaxhttps://pharmaphorum.com/news/uk-signs-coronavirus-vaccine-deals-with-jj-and-novavax/
Novavax says COVID-19 vaccine could be approved by year-endNovavax’s COVID-19 vaccine produced higher levels of neutralising antibodies than produced by recovered patients in an early trial, Share XNovavax says COVID-19 vaccine could be approved by year-endhttps://pharmaphorum.com/news/novavax-says-covid-19-vaccine-could-be-approved-by-year-end/
US snaps up first supplies of Regeneron’s COVID-19 antibodyHard on the heels of Regeneron moving its COVID-19 antibody cocktail into late-stage testing, the US government has Share XUS snaps up first supplies of Regeneron’s COVID-19 antibodyhttps://pharmaphorum.com/news/us-snaps-up-first-supplies-of-regenerons-covid-19-antibody/
Novavax is latest biotech to begin coronavirus vaccine trialUS biotech Novavax has begun a phase 1 study of its coronavirus vaccine, as the number in clinical development reached double figures. The Share XNovavax is latest biotech to begin coronavirus vaccine trialhttps://pharmaphorum.com/news/novavax-is-latest-biotech-to-begin-coronavirus-vaccine-trial/
Novavax gets $384m for clinical trial of COVID-19 vaccineGlobal vaccine development organisation CEPI is to invest $384 million additional funding in a COVID-19 jab being developed Share XNovavax gets $384m for clinical trial of COVID-19 vaccinehttps://pharmaphorum.com/news/novavax-gets-384m-for-clinical-trial-of-covid-19-vaccine/
